A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Jazz Pharmaceuticals
AstraZeneca
Taiho Oncology, Inc.
Hoffmann-La Roche
Hoffmann-La Roche
Jazz Pharmaceuticals
Merck Sharp & Dohme LLC
Eurofarma Laboratorios S.A.
Merck Sharp & Dohme LLC
Taiho Pharmaceutical Co., Ltd.
Merck Sharp & Dohme LLC
Boston Scientific Corporation
Jiangsu HengRui Medicine Co., Ltd.
Merck Sharp & Dohme LLC
Merck KGaA, Darmstadt, Germany
Shenzhen Hornetcorn Bio-technology Company, LTD
Amgen
Amgen
Sanofi
Sanofi